| Pfizer AG - Litfulo 50 mg, Hartkapseln | | 69695 | | 01 | | Litfulo 50 mg | | Hartkapseln | | | | | | 03.02.2025 | | |
| | Composition | | ritlecitinibum 50 mg ut ritlecitinibi tosilas, cellulosum microcristallinum, lactosum monohydricum 21.269 mg, crospovidonum, glyceroli dibehenas, Kapselhülle: hypromellosum, E 171, E 172 (flavum), E 133, Drucktinte: lacca, propylenglycolum, ammoniae solutio concentrata, E 172 (nigrum), kalii hydroxidum, pro capsula. | | Packungsbestandteile | | Capsules | | | | Principe actif | Concentr. |
|---|
| Ritlecitinibum | 50 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Flavum) | | | | (Nigrum) | | | | Ammoniae Solutio Concentrata | | | | Cellulosum Microcristallinum | | | | Crospovidonum | | | | E 133 | | color. | | E 171 | | color. | | E 172 | | color. | | Glyceroli Dibehenas | | | | Hypromellosum | | Kapselhülle | | Kalii Hydroxidum | | | | Lacca | | Drucktinte | | Lactose Monohydrate | 21.269 mg | | | Pro Capsula | | | | Propylenglycol | | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 30 | DDP | DDP | B | | Non |
|
|
